<DOC>
	<DOCNO>NCT00658801</DOCNO>
	<brief_summary>The curative option pancreatic cancer patient surgery , patient within 20 % possible radical surgery . Accordingly , concurrent chemo-radiation therapy generally use palliation unresectable pancreatic cancer patient . So far , use 5-fluorouracil ( 5-FU ) traditional method chemotherapy . However , day , oral anti-cancer medicine , capecitabine ( Xeloda® ) , develop consider alternative medicine 5-fluorouracil ( 5-FU ) . Furthermore , accord recent result clinical trial , clinical use capecitabine ( Xeloda® ) radiation therapy prove effective safe . Proton therapy new radiation therapy remain energy release reach tumor , deliver effective dose radiation minimize exposure normal tissue . The purpose trial improve therapeutic effect use proton therapy chemotherapy concurrently .</brief_summary>
	<brief_title>Study Respiratory Gated Proton Beam Radiotherapy Inoperable Pancreas Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<criteria>Pathologically confirm adenocarcinoma pancreas serum CA199 level high normal limit pancreas cancercompatible radiological feature one CT/MRI/PET scan Unresectable disease base institutional standard criterion unresectability recurrent disease follow radical surgery . There evidence metastatic disease major viscera peritoneal seed Patients biliary gastroduodenal obstruction must drainage prior start chemoradiation All malignant disease must encompassable within single irradiation field ( 15x15cm maximum ) All patient must radiographically assessable disease No previous irradiation plan field Age ≥ 18 year Performance status 0 2 Eastern Cooperative Oncology Group ( ECOG ) score Required Entry Labortory Parameters : WBC count ≥ 2,000/mm3 hemoglobin level ≥ 7.5 g/dL platelet count ≥ 100,000/mm3 total bilirubin ≤ 2.0 mg/dL ( Patients elevate bilirubin due obstruction stented bilirubin decrease ≤ 2.0 mg/dL prior study entry ) creatinine ≤ 3.0 mg/dL Oral intake ( include Jtube feeding ) ≥ 1,500 calories/day maintain . There evidence metastasis major viscera peritoneal seed . Age &lt; 18 year Previous history RT adjacent plan field Poor performance status 3 4 Eastern Cooperative Oncology Group ( ECOG ) score Pregnant breast feeding status Previous history uncontrolled malignancy within 2 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>